Statistics from Altmetric.com
ABSTRACT FROM: Samara MT, Leucht C, Leeflang MM, et al. Early improvement as a predictor of later response to antipsychotics in schizophrenia: a diagnostic test review. Am J Psychiatry 2015;172:617–29.
What is already known on this topic?
Because there is no conclusive evidence on whether early signs of improvement predict later non-response to antipsychotics in patients with schizophrenia spectrum disorders, the treatment guidelines for schizophrenia, such as those from National Institute for Health and Care Excellence,1 remain unclear as to when a treatment should be changed if patients are unresponsive to a recently prescribed antipsychotic.
Therefore, Samara and colleagues performed this diagnostic meta-analysis to examine whether a lack of significant improvement at week 2 could predict ultimate treatment failure.
Methods of the study
The diagnostic test meta-analysis using mostly individual patient data was conducted to assess whether lack of improvement at week 2 predicts later non-response …
Competing interests TK has received speaker's honoraria from AbbVie, Astellas, Daiichi Sankyo, Dainippon Sumitomo, Eisai, Eli Lilly, GlaxoSmithKline, Janssen, Yoshitomi, Otsuka, Meiji, Shionogi, Tanabe-Mitsubishi, Tsumura, Novartis and Pfizer, and grants from Astellas within the past 2 years.
Provenance and peer review Commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.